China Biologic Products Holdings, Inc.
CBPO
CBPO was delisted on the 20th of April, 2021.
143 hedge funds and large institutions have $2.04B invested in China Biologic Products Holdings, Inc. in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 50 increasing their positions, 56 reducing their positions, and 36 closing their positions.
11% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 56
12% less funds holding
Funds holding: 163 → 143 (-20)
37% less capital invested
Capital invested by funds: $3.22B → $2.04B (-$1.19B)
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
42% less call options, than puts
Call options by funds: $5.34M | Put options by funds: $9.15M
53% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$18.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.1M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
+$17.1M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$15.3M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$12.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Warburg Pincus
New York
|
-$831M |
| 2 |
MAM
Myriad Asset Management
North Point,
Hong Kong
|
-$16.7M |
| 3 |
Renaissance Technologies
New York
|
-$13.5M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$13.3M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$12.4M |
CBPO Hedge Fund Activity: Q4 2016 in Review
143 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in China Biologic Products Holdings, Inc. (CBPO) for Q4 2016, worth a combined $2.04B — down 37% from $3.22B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of CBPO and 17 opened new positions — a net loss of 19 holders — while 56 trimmed existing stakes and 50 added.
The largest buyer was AllianceBernstein, adding an estimated $18.8M. The largest seller was Warburg Pincus, exiting entirely with an estimated $831M sold.
- 143 institutional investors held China Biologic Products Holdings, Inc. (CBPO) as of Q4 2016, down from 163 in Q3 2016.
- Funds reported $2.04B of China Biologic Products Holdings, Inc. stock for Q4 2016, down 37% quarter-over-quarter.
- 17 funds opened new China Biologic Products Holdings, Inc. positions in Q4 2016 and 36 closed out, a net change of -19 holders.
- The largest China Biologic Products Holdings, Inc. buyer in Q4 2016 was AllianceBernstein, an estimated $18.8M added.
- The largest China Biologic Products Holdings, Inc. seller in Q4 2016 was Warburg Pincus, an estimated $831M sold.
Based on aggregated 13F filings for Q4 2016.